Profile data is unavailable for this security.
About the company
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio includes EndoDrill GI Upper for stomach biopsy, EndoDrill GI Lower for intestinal biopsy, EndoDrill GI Lung for lung biopsy, EndoDrill Therapy to pass displacements in different organs for placement of conductors, balloons and stents for treatment, EndoDrill Needle for breasts biopsy, as well as EndoDrill Model X for multiple areas and falls under independent research project. Products are distributed to hospitals with endoscopy specialists’ centers and surgical wards. The Company’s primary distribution focus is Scandinavian countries.
- Revenue in SEK (TTM)149.00k
- Net income in SEK-13.30m
- Incorporated2013
- Employees4.00
- LocationBibbInstruments ABScheeletorget 1, byggnad 405LUND 223 81SwedenSWE
- Phone+46 463782829
- Websitehttps://www.bibbinstruments.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SpectraCure AB (publ) | 1.42m | -53.17m | 54.65m | 13.00 | -- | 0.393 | -- | 38.43 | -0.165 | -0.165 | 0.0052 | 0.2468 | 0.012 | -- | 1.90 | 109,384.60 | -44.68 | -13.14 | -49.10 | -14.07 | 835.02 | 243.69 | -3,739.03 | -592.49 | -- | -197.29 | 0.0325 | -- | -46.15 | -13.97 | -12.54 | -- | 0.1962 | -- |
| ScandiDos AB | 59.37m | -1.38m | 56.56m | 25.00 | -- | 1.31 | 91.66 | 0.9526 | -0.0242 | -0.0242 | 1.04 | 0.7576 | 0.8416 | 1.52 | 5.60 | 2,283,539.00 | -1.96 | -8.71 | -3.04 | -14.68 | 48.30 | 52.29 | -2.33 | -10.67 | 0.7927 | -- | 0.00 | -- | 2.34 | 1.55 | 102.23 | -- | -11.62 | -- |
| Luxbright AB | 11.49m | -19.25m | 57.27m | 12.00 | -- | 2.13 | -- | 4.99 | -0.1644 | -0.1644 | 0.0968 | 0.2067 | 0.2788 | 7.73 | 2.68 | -- | -46.74 | -56.30 | -59.61 | -66.28 | -6.22 | -79.12 | -167.60 | -450.36 | 1.22 | -83.81 | 0.1076 | -- | 26.52 | 79.40 | -9.86 | -- | -- | -- |
| Kontigo Care AB | 29.13m | -2.07m | 58.70m | 10.00 | -- | 1.16 | 16.22 | 2.02 | -0.0589 | -0.0589 | 0.8262 | 1.43 | 0.4487 | -- | 7.97 | -- | -3.19 | 0.296 | -3.98 | 0.4064 | 125.51 | 129.99 | -7.12 | 0.4638 | -- | -- | 0.00 | -- | -3.66 | 7.41 | -367.61 | -- | 17.15 | -- |
| Episurf Medical AB | 16.10m | -58.10m | 61.23m | 18.00 | -- | 1.29 | -- | 3.80 | -0.0533 | -0.0533 | 0.0138 | 0.0286 | 0.2043 | -- | 4.54 | 894,444.40 | -72.97 | -47.42 | -86.27 | -52.18 | -- | -- | -357.14 | -701.12 | 1.41 | -579.00 | 0.0935 | -- | 22.90 | 18.13 | 23.42 | -- | 7.81 | -- |
| Neola Medical AB | 0.00 | -10.99m | 61.42m | 8.00 | -- | 0.7829 | -- | -- | -0.1479 | -0.1479 | 0.00 | 1.01 | 0.00 | -- | -- | 0.00 | -13.81 | -15.62 | -14.65 | -16.86 | -- | 5,384.30 | -- | -6,523.93 | 5.61 | -- | 0.00 | -- | -- | -- | -11.70 | -- | 35.63 | -- |
| Redsense Medical AB (publ) | 30.67m | 302.00k | 73.02m | 4.00 | 221.67 | 2.03 | 123.55 | 2.38 | 0.02 | 0.02 | 1.86 | 2.18 | 0.7697 | 1.96 | 6.61 | 6,134,600.00 | 0.7578 | -14.28 | 0.8514 | -15.86 | 61.45 | 68.85 | 0.9846 | -32.79 | 4.69 | -- | 0.00 | -- | 12.85 | 16.26 | 107.58 | -- | -53.01 | -- |
| Scandinavian ChemoTech AB | 11.68m | -8.70m | 76.36m | 1.00 | -- | 13.27 | -- | 6.54 | -0.3727 | -0.3727 | 0.5003 | 0.2653 | 0.727 | 0.5917 | 2.66 | 1,946,333.00 | -54.15 | -92.70 | -83.07 | -131.46 | 82.15 | 104.65 | -74.49 | -866.06 | 0.861 | -5.61 | 0.00 | -- | 132.67 | 63.85 | 34.96 | -- | -59.68 | -- |
| BibbInstruments AB | 149.00k | -13.30m | 86.77m | 4.00 | -- | 2.03 | -- | 582.38 | -0.3802 | -0.3802 | 0.0041 | 1.05 | 0.0038 | 2.06 | 2.71 | 37,250.00 | -33.98 | -36.85 | -35.53 | -40.06 | 30.87 | 59.14 | -8,922.82 | -22,555.64 | 6.67 | -- | 0.00 | -- | -- | -- | -15.85 | -- | -1.52 | -- |
| Bioretec Oy | -1.06tn | -1.06tn | 88.68m | 57.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -57.56 | -- | -77.31 | -- | 70.90 | -- | -128.20 | -- | -- | -- | -- | 16.32 | 21.07 | -21.78 | -- | -- | -- |
| SyntheticMR AB (publ) | 57.05m | -54.93m | 98.27m | 41.00 | -- | 0.6659 | -- | 1.72 | -0.9057 | -0.9057 | 0.9467 | 1.65 | 0.3678 | -- | 0.8733 | 1,391,415.00 | -35.42 | -7.92 | -51.34 | -10.51 | 10.41 | 56.07 | -96.28 | -14.37 | -- | -8.73 | 0.0450 | -- | 2.47 | 3.20 | -241.50 | -- | 7.37 | -- |
| Iconovo AB | 1.59m | -41.23m | 104.83m | 19.00 | -- | 0.4425 | -- | 66.06 | -1.67 | -1.67 | 0.0537 | 2.46 | 0.0117 | -- | 0.2608 | 63,475.20 | -30.39 | -28.39 | -33.14 | -31.51 | 901.69 | 159.24 | -2,598.41 | -295.86 | -- | -138.02 | 0.0391 | -- | -58.55 | -24.22 | 10.36 | -- | 22.28 | -- |
| Observe Medical ASA | 15.74m | -116.01m | 104.87m | 4.00 | -- | 4.29 | -- | 6.66 | -26.57 | -26.57 | 3.29 | 0.1909 | 0.1118 | 2.87 | 8.29 | 3,350,800.00 | -82.38 | -42.22 | -205.00 | -64.14 | 6.24 | 30.17 | -737.14 | -327.97 | 0.1175 | -3.72 | 0.9572 | -- | -33.85 | 153.47 | -98.73 | -- | -2.97 | -- |
| Arcoma AB | 132.94m | 4.35m | 111.61m | 31.00 | 24.33 | 1.52 | 9.63 | 0.8395 | 0.3205 | 0.3205 | 9.87 | 5.13 | 1.45 | 2.92 | 13.71 | 4,288,452.00 | 4.75 | 2.16 | 6.66 | 3.75 | 40.45 | 37.95 | 3.27 | 1.40 | 2.04 | -- | 0.00 | 0.00 | -3.81 | 3.24 | 336.00 | 11.08 | -9.43 | -- |
| Immunovia AB (publ) | 785.00k | -125.52m | 120.27m | 9.00 | -- | -- | -- | 153.21 | -0.3569 | -0.3569 | 0.0024 | -0.021 | 0.0156 | -- | 0.264 | 87,222.22 | -249.16 | -48.08 | -827.53 | -52.27 | -7,231.59 | -6,932.30 | -15,989.68 | -17,625.51 | 0.6282 | -3.00 | 1.68 | -- | -40.89 | 21.20 | 75.26 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to BibbInstruments AB's reporting currency: Swedish Krona SEK
8.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aktia Bank Plc (Investment Management)as of 31 Oct 2025 | 2.29m | 5.61% |
| Schroder Investment Management (Europe) SA (Finland)as of 30 Jun 2025 | 1.02m | 2.50% |
| AIFM Capital ABas of 30 Jun 2024 | 174.21k | 0.43% |
Data from 31 Dec 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
